Author | Tony Hagen

Articles

Studies Reveal Positive Results for Infliximab Biosimilar

June 18, 2020

Article

In studies presented this month at the European E-Congress of Rheumatology 2020, investigators revealed positive findings for the infliximab biosimilar CT-P13 (Inflectra, Remsima), which is developed by Celltrion of Incheon, Republic of Korea.

x